Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Genetics Sacks CEO and President Ryals

For an updated version of this story, click here.

 

NEW YORK, Feb. 26 - Paradigm Genetics has fired its CEO and President John A. Ryals and has appointed Chief Scientific Officer John E. Hamer to take the helm "while a global search is conducted."

 

Ryals founded the company in 1997 and has since served as CEO and president.

 

Hamer, who received his PhD in microbiology from the University of California, Davis, came to Paradigm from Purdue University where he was an adjunct professor of microbiology and immunology.

 

Paradigm did not offer a reason for Ryals' sudden dismissal and messages left with a company official late on Tuesday afternoon were not immediately returned.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.